Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             51 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A History of Lung Cancer: the recalcitrant disease Ahmed, Merina
2014
15 7 p. 687
artikel
2 A near miss for prostate cancer immunotherapy Parker, Chris
2014
15 7 p. 669-671
artikel
3 ASTRO supports radiotherapy self-referral report Burki, Talha Khan
2014
15 7 p. e255
artikel
4 Baseline standards for paediatric oncology nursing care in low to middle income countries: position statement of the SIOP PODC Nursing Working Group Day, Sara
2014
15 7 p. 681-682
artikel
5 Breast cancer in China Fan, Lei
2014
15 7 p. e279-e289
artikel
6 Breast cancer in older women: predicting adjuvant benefit Brain, Etienne
2014
15 7 p. 672-674
artikel
7 Cancer in refugees in Jordan and Syria between 2009 and 2012: challenges and the way forward in humanitarian emergencies Spiegel, Paul
2014
15 7 p. e290-e297
artikel
8 Carboplatin for early triple-negative breast cancer? Valero, Vicente
2014
15 7 p. 676-678
artikel
9 Carboplatin plus paclitaxel scheduling for advanced ovarian cancer Baratti, Dario
2014
15 7 p. e249
artikel
10 Carboplatin plus paclitaxel scheduling for advanced ovarian cancer Shimokata, Tomoya
2014
15 7 p. e249-e250
artikel
11 Carboplatin plus paclitaxel scheduling for advanced ovarian cancer – Authors' reply Pignata, Sandro
2014
15 7 p. e250-e251
artikel
12 Classification of endometrial carcinoma: more than two types Murali, Rajmohan
2014
15 7 p. e268-e278
artikel
13 Clinical use of dendritic cells for cancer therapy Anguille, Sébastien
2014
15 7 p. e257-e267
artikel
14 Correction to Lancet Oncol 2014; 15: 621 2014
15 7 p. e253
artikel
15 Correction to Lancet Oncol 2014; 15: 606 2014
15 7 p. e253
artikel
16 Correction to Lancet Oncol 2013; 14: 1242 2014
15 7 p. e253
artikel
17 Decoding Annie Parker van Dorn, Aaron
2014
15 7 p. 685
artikel
18 Drawing Women's Cancer Clague, Stephanie
2014
15 7 p. 685-686
artikel
19 Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial Sartor, Oliver
2014
15 7 p. 738-746
artikel
20 18F-FDG PET/CT scans for children and adolescents Lassmann, Michael
2014
15 7 p. e243-e244
artikel
21 18F-FDG PET/CT scans for children and adolescents – Authors' reply Daldrup-Link, Heike
2014
15 7 p. e244
artikel
22 Full-spectrum colonoscopy for adenoma detection Dawwas, Muhammad F
2014
15 7 p. e244-e245
artikel
23 Full-spectrum colonoscopy for adenoma detection – Author reply Gralnek, Ian M
2014
15 7 p. e245-e246
artikel
24 Future priorities for the IARC Monographs Straif, Kurt
2014
15 7 p. 683-684
artikel
25 HER2-positive breast cancer: a new piece of the puzzle Gnant, Michael
2014
15 7 p. 668-669
artikel
26 Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial Kwon, Eugene D
2014
15 7 p. 700-712
artikel
27 Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial Vitolo, Umberto
2014
15 7 p. 730-737
artikel
28 Letermovir: a novel drug for cytomegalovirus prophylaxis Bagcchi, Sanjeet
2014
15 7 p. e256
artikel
29 Life, love, and loss: a tale of terminal cancer Gourd, Katherine
2014
15 7 p. 688
artikel
30 Lymphoma-directed conditioning for aggressive lymphoma Sureda, Anna
2014
15 7 p. 678-679
artikel
31 Minimally-invasive approach for rectal cancer surgery Brouquet, Antoine
2014
15 7 p. 680-681
artikel
32 Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial von Minckwitz, Gunter
2014
15 7 p. 747-756
artikel
33 On the Cancer Frontier Burki, Talha Khan
2014
15 7 p. 686-687
artikel
34 Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial Jeong, Seung-Yong
2014
15 7 p. 767-774
artikel
35 Organs from some cancer patients safe for transplantation Tanday, Sanjay
2014
15 7 p. e254
artikel
36 Origins research in large cell lymphoma—time for action? Witzig, Thomas E
2014
15 7 p. 674-675
artikel
37 PET-CT before colorectal cancer surgery is not beneficial Tanday, Sanjay
2014
15 7 p. e256
artikel
38 Plain-packaging challenge and e-cigarette regulation Burki, Talha Khan
2014
15 7 p. e254
artikel
39 Play to Cure: Genes in Space Coburn, Cassandra
2014
15 7 p. 688
artikel
40 Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial Gregorc, Vanesa
2014
15 7 p. 713-721
artikel
41 Prostate cancer bone metastases: not so systemic after all Logothetis, Christopher J
2014
15 7 p. 675-676
artikel
42 Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial Glass, Bertram
2014
15 7 p. 757-766
artikel
43 Rituximab for follicular lymphoma: watch and wait, watch and worry, or watch and live? LeBlanc, Thomas
2014
15 7 p. e251-e252
artikel
44 Stereotactic radiosurgery for patients with brain metastases Alongi, Filippo
2014
15 7 p. e246-e247
artikel
45 Stereotactic radiosurgery for patients with brain metastases Takiguchi, Yuichi
2014
15 7 p. e247-e248
artikel
46 Stereotactic radiosurgery for patients with brain metastases – Authors' reply Yamamoto, Masaaki
2014
15 7 p. e248
artikel
47 Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial Krop, Ian E
2014
15 7 p. 689-699
artikel
48 UK pharmaceutical industry under threat The Lancet Oncology,
2014
15 7 p. 667
artikel
49 Uruguay versus tobacco giant Phillip Morris International Burki, Talha Khan
2014
15 7 p. e255
artikel
50 Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study de Glas, Nienke A
2014
15 7 p. 722-729
artikel
51 VeriStrat validated in patients with non-small-cell lung cancer Butts, Charles A
2014
15 7 p. 671-672
artikel
                             51 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland